• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有脂肪代谢障碍综合征的人类免疫缺陷病毒感染女性的高雄激素血症

Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.

作者信息

Hadigan C, Corcoran C, Piecuch S, Rodriguez W, Grinspoon S

机构信息

Neuroendocrine Unit, Massachusetts General Hospital, Boston 02114, USA.

出版信息

J Clin Endocrinol Metab. 2000 Oct;85(10):3544-50. doi: 10.1210/jcem.85.10.6923.

DOI:10.1210/jcem.85.10.6923
PMID:11061499
Abstract

A novel lipodystrophy syndrome characterized by insulin resistance, hypertriglyceridemia, and fat redistribution has recently been described in human immunodeficiency virus (HIV)-infected men and women. Women with the HIV lipodystrophy syndrome exhibit a marked increase in waist-to-hip ratio and truncal adiposity; however, it is unknown whether androgen levels are increased in these patients. In this study, we assessed androgen levels in female patients with clinical lipodystrophy based on evidence of significant fat redistribution in the trunk, extremities, neck and/or face (LIPO: n = 9; age, 35.7+/-1.7 yr; BMI, 24.7+/-0.8 kg/m2) in comparison with age- and BMI-matched nonlipodystrophic HIV-infected females (NONLIPO: n = 14; age, 37.6+/-1.1 yr; BMI, 23.4+/-0.6 kg/m2) and healthy non-HIV-infected control subjects (C: n = 16; age, 35.8+/-0.9 yr; BMI, 23.1+/-0.4 kg/m2). Fasting insulin, lipid levels, virologic parameters, and regional body composition using dual energy x-ray absorptiometry were also assessed. Total testosterone [ LIPO, 33+/-6 ng/dL (1.1+/-0.2 nmol/L); NONLIPO, 17+/-2 ng/dL (0.6+/-0.1 nmol/L); C, 23+/-2 ng/dL (0.8+/-0.1 nmol/L); P < 0.05 LIPO vs. C and LIPO vs. NONLIPO] and free testosterone determined by equilibrium dialysis [LIPO, 4.5+/-0.9 pg/mL (16+/-3 pmol/L); NONLIPO, 1.7+/-0.2 pg/mL (6+/-1 pmol/L); C, 2.4+/-0.2 pg/mL (8+/-1 pmol/L); P < 0.05 LIPO vs. C and LIPO vs. NONLIPO] were increased in the lipodystrophic patients. Sex hormone-binding globulin levels were not significantly different between LIPO and C, but were significantly lower in the LIPO vs. NONLIPO patients (LIPO 84+/-7 vs. NONLIPO 149+/-17 nmol/L, P < 0.05). The LH/FSH ratio was significantly increased in the LIPO group compared with the NONLIPO and C subjects (LIPO, 2.0+/-0.6; NONLIPO, 1.1+/-0.1; C, 0.8+/-0.1; P < 0.05 LIPO vs. NONLIPO and LIPO vs. C). Body fat distribution was significantly different between LIPO and C subjects. Trunk to extremity fat ratio (1.46+/-0.17 vs. 0.75+/-0.05, LIPO vs. C, P < 0.05) was increased and extremity to total fat ratio decreased (0.40+/-0.03 vs. 0.55+/-0.01, LIPO vs. C, P < 0.05). In contrast, fat distribution was not different in the NONLIPO group vs. control subjects. Among the HIV-infected patients, free testosterone correlated with percent truncal fat (trunk fat/trunk mass) (r = 0.43, P = 0.04). These data suggest that hyperandrogenemia is another potentially important feature of the HIV-lipodystrophy syndrome in women. Additional studies are necessary to determine the clinical significance of increased androgen levels and the relationship of hyperandrogenism to fat redistribution and insulin resistance in this population of patients.

摘要

最近在感染人类免疫缺陷病毒(HIV)的男性和女性中发现了一种以胰岛素抵抗、高甘油三酯血症和脂肪重新分布为特征的新型脂肪营养不良综合征。患有HIV脂肪营养不良综合征的女性腰臀比和躯干肥胖显著增加;然而,这些患者的雄激素水平是否升高尚不清楚。在本研究中,我们评估了临床诊断为脂肪营养不良的女性患者的雄激素水平,这些患者躯干、四肢、颈部和/或面部有明显脂肪重新分布的证据(脂肪营养不良组:n = 9;年龄,35.7±1.7岁;体重指数,24.7±0.8kg/m²),并与年龄和体重指数匹配的未患脂肪营养不良的HIV感染女性(非脂肪营养不良组:n = 14;年龄,37.6±1.1岁;体重指数,23.4±0.6kg/m²)以及健康的未感染HIV的对照受试者(对照组:n = 16;年龄,35.8±0.9岁;体重指数,23.1±0.4kg/m²)进行比较。还评估了空腹胰岛素、血脂水平、病毒学参数以及使用双能X线吸收法测定的局部身体成分。脂肪营养不良患者的总睾酮水平升高[脂肪营养不良组,33±6ng/dL(1.1±0.2nmol/L);非脂肪营养不良组,17±2ng/dL(0.6±0.1nmol/L);对照组,23±2ng/dL(0.8±0.1nmol/L);脂肪营养不良组与对照组比较以及脂肪营养不良组与非脂肪营养不良组比较,P < 0.05],通过平衡透析法测定的游离睾酮水平也升高[脂肪营养不良组,4.5±0.9pg/mL(16±3pmol/L);非脂肪营养不良组,1.7±0.2pg/mL(6±1pmol/L);对照组,2.4±0.2pg/mL(8±1pmol/L);脂肪营养不良组与对照组比较以及脂肪营养不良组与非脂肪营养不良组比较,P < 0.05]。脂肪营养不良组与对照组的性激素结合球蛋白水平无显著差异,但脂肪营养不良组与非脂肪营养不良组患者相比显著降低(脂肪营养不良组84±7与非脂肪营养不良组149±17nmol/L,P < 0.05)。与非脂肪营养不良组和对照组相比,脂肪营养不良组的促黄体生成素/促卵泡激素比值显著升高(脂肪营养不良组,2.0±0.6;非脂肪营养不良组,1.1±0.1;对照组,0.8±0.1;脂肪营养不良组与非脂肪营养不良组比较以及脂肪营养不良组与对照组比较,P < 0.05)。脂肪营养不良组与对照组的身体脂肪分布有显著差异。躯干与四肢脂肪比增加(脂肪营养不良组1.46±0.17与对照组0.75±0.05,P < 0.05),四肢与总脂肪比降低(脂肪营养不良组0.40±0.03与对照组0.55±0.01,P < 0.05)。相比之下,非脂肪营养不良组与对照受试者的脂肪分布无差异。在感染HIV的患者中,游离睾酮与躯干脂肪百分比(躯干脂肪/躯干质量)相关(r = 0.43,P = 0.04)。这些数据表明,高雄激素血症是女性HIV脂肪营养不良综合征的另一个潜在重要特征。需要进一步研究以确定雄激素水平升高的临床意义以及该患者群体中高雄激素血症与脂肪重新分布和胰岛素抵抗的关系。

相似文献

1
Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.患有脂肪代谢障碍综合征的人类免疫缺陷病毒感染女性的高雄激素血症
J Clin Endocrinol Metab. 2000 Oct;85(10):3544-50. doi: 10.1210/jcem.85.10.6923.
2
Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.人类免疫缺陷病毒相关脂肪代谢障碍中生长激素动态变化的评估
J Clin Endocrinol Metab. 2001 Feb;86(2):504-10. doi: 10.1210/jcem.86.2.7175.
3
Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.在发生脂肪重新分布的人类免疫缺陷病毒感染受试者中,游离脂肪酸浓度升高与对标准葡萄糖刺激的胰岛素反应增加有关。
Metabolism. 2002 Feb;51(2):260-6. doi: 10.1053/meta.2002.29999.
4
Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.人类免疫缺陷病毒感染女性的空腹高胰岛素血症与局部身体成分变化
J Clin Endocrinol Metab. 1999 Jun;84(6):1932-7. doi: 10.1210/jcem.84.6.5738.
5
Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.人类免疫缺陷病毒感染男性的空腹高胰岛素血症:与身体组成、性腺功能及蛋白酶抑制剂使用的关系
J Clin Endocrinol Metab. 2000 Jan;85(1):35-41. doi: 10.1210/jcem.85.1.6264.
6
Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.合并或未合并脂肪代谢障碍的HIV感染患者中,靶组织对生长激素的敏感性不同以及生长激素对葡萄糖的反应不同。
Scand J Infect Dis. 2004;36(11-12):832-9. doi: 10.1080/00365540410021162.
7
Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.脂肪营养不良的人类免疫缺陷病毒感染患者体内的胰岛素样生长因子、胰岛素样生长因子结合蛋白、胰岛素样生长因子结合蛋白-3蛋白酶及生长激素结合蛋白
Metabolism. 2004 Dec;53(12):1565-73. doi: 10.1016/j.metabol.2004.06.025.
8
Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.在出现脂肪重新分布的HIV感染患者中,口服葡萄糖刺激前及刺激期间胰岛素原分泌受损。
Metabolism. 2007 Jul;56(7):939-46. doi: 10.1016/j.metabol.2007.02.007.
9
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.获得性免疫缺陷综合征消瘦女性的身体成分与内分泌功能
J Clin Endocrinol Metab. 1997 May;82(5):1332-7. doi: 10.1210/jcem.82.5.3907.
10
Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.血糖正常的脂肪营养不良HIV感染患者的高胰岛素原血症
Eur J Clin Invest. 2006 Jun;36(6):436-45. doi: 10.1111/j.1365-2362.2006.01640.x.

引用本文的文献

1
Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.人类免疫缺陷病毒/获得性免疫缺陷综合征与不孕:高效抗逆转录病毒治疗时代的新问题。
Fertil Steril. 2011 Sep;96(3):546-53. doi: 10.1016/j.fertnstert.2011.05.094. Epub 2011 Jun 30.
2
Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women.肥胖的HIV感染女性中胰岛素抵抗与全身肌间脂肪组织含量高及腿部皮下脂肪组织含量低的独立关联。
Am J Clin Nutr. 2007 Jul;86(1):100-6. doi: 10.1093/ajcn/86.1.100.
3
Adipocyte, adipose tissue, and infectious disease.
脂肪细胞、脂肪组织与传染病。
Infect Immun. 2007 Mar;75(3):1066-78. doi: 10.1128/IAI.01455-06. Epub 2006 Nov 21.
4
Protease inhibitor-induced diabetic complications : incidence, management and prevention.蛋白酶抑制剂诱发的糖尿病并发症:发病率、管理与预防
Drug Saf. 2005;28(3):209-26. doi: 10.2165/00002018-200528030-00003.